TargetMol
Acefylline (Theophylline-7-acetic acid), a stimulant drug of the xanthine chemical class, acts as an adenosine receptor antagonist. It is combined with diphenhydramine in the pharmaceutical preparation Etanautine to help offset its stimulant effects
More Information
Supplier Page
ICG001
100 mg
| 98.63%
TargetMol
ICG-001 antagonizes Wnt/β-catenin/TCF-mediated transcription and specifically binds to element-binding protein (CREB)-binding protein (CBP) with IC50 of 3 μM, but is not the related transcriptional coactivator p300.
More Information
Supplier Page
ICG001
25 mg
| 98.63%
TargetMol
ICG-001 antagonizes Wnt/β-catenin/TCF-mediated transcription and specifically binds to element-binding protein (CREB)-binding protein (CBP) with IC50 of 3 μM, but is not the related transcriptional coactivator p300.
More Information
Supplier Page
ICG001
5 mg
| 98.63%
TargetMol
ICG-001 antagonizes Wnt/β-catenin/TCF-mediated transcription and specifically binds to element-binding protein (CREB)-binding protein (CBP) with IC50 of 3 μM, but is not the related transcriptional coactivator p300.
More Information
Supplier Page
IM-12
10 mg
| 99.42%
TargetMol
Tezacaftor
100 mg
| Purity Not Available
TargetMol
Tezacaftor (VX661) is a small molecule that can be used as a corrector of the cystic fibrosis transmembrane conductance regulator (CFTR) gene function.
More Information
Supplier Page
Tezacaftor
10 mg
| Purity Not Available
TargetMol
Tezacaftor (VX661) is a small molecule that can be used as a corrector of the cystic fibrosis transmembrane conductance regulator (CFTR) gene function.
More Information
Supplier Page
Tezacaftor
50 mg
| Purity Not Available
TargetMol
Tezacaftor (VX661) is a small molecule that can be used as a corrector of the cystic fibrosis transmembrane conductance regulator (CFTR) gene function.
More Information
Supplier Page
TargetMol
TargetMol